{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T20:04:16Z","timestamp":1789416256984,"version":"build-2803163510"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T00:00:00Z","timestamp":1567123200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T00:00:00Z","timestamp":1567123200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s00261-019-02203-z","type":"journal-article","created":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T05:21:52Z","timestamp":1567228912000},"page":"3480-3485","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Iatrogenic celiac and hepatic artery dissections during intra-arterial regional tumor therapies: a 16-year retrospective review"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7880-3565","authenticated-orcid":false,"given":"Erica S.","family":"Alexander","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Nadolski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Soulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. William","family":"Stavropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence P.","family":"Gade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxim","family":"Itkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Shamimi-Noori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,30]]},"reference":[{"issue":"7","key":"2203_CR1","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.jvir.2010.02.028","volume":"21","author":"SW Kwan","year":"2010","unstructured":"Kwan SW, Kerlan RK, Jr., Sunshine JH (2010) Utilization of interventional oncology treatments in the United States. J Vasc Interv Radiol 21 (7):1054-1060. \n                    https:\/\/doi.org\/10.1016\/j.jvir.2010.02.028","journal-title":"J Vasc Interv Radiol"},{"issue":"8","key":"2203_CR2","doi-asserted-by":"publisher","first-page":"12116","DOI":"10.1002\/jcp.28019","volume":"234","author":"JY Sun","year":"2019","unstructured":"Sun JY, Yin T, Zhang XY, Lu XJ (2019) Therapeutic advances for patients with intermediate hepatocellular carcinoma. J Cell Physiol 234 (8):12116-12121. \n                    https:\/\/doi.org\/10.1002\/jcp.28019","journal-title":"J Cell Physiol"},{"issue":"4","key":"2203_CR3","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1053\/j.tvir.2018.07.002","volume":"21","author":"BE Kouri","year":"2018","unstructured":"Kouri BE (2018) Interventional Oncology: Optimizing Transarterial Therapies for the Treatment of Hepatic Malignancy. Tech Vasc Interv Radiol 21 (4):205-222. \n                    https:\/\/doi.org\/10.1053\/j.tvir.2018.07.002","journal-title":"Tech Vasc Interv Radiol"},{"issue":"4","key":"2203_CR4","first-page":"412","volume":"17","author":"J Ma","year":"2017","unstructured":"Ma J, Gimenez JM, Sandow T, Devun D, Kirsch D, Gulotta P, Gilbert P, Kay D (2017) Intraarterial Liver-Directed Therapies: The Role of Interventional Oncology. Ochsner J 17 (4):412-416","journal-title":"Ochsner J"},{"issue":"2","key":"2203_CR5","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/jso.2930600210","volume":"60","author":"DH Berger","year":"1995","unstructured":"Berger DH, Carrasco CH, Hohn DC, Curley SA (1995) Hepatic artery chemoembolization or embolization for primary and metastatic liver tumors: post-treatment management and complications. J Surg Oncol 60 (2):116-121","journal-title":"J Surg Oncol"},{"issue":"49","key":"2203_CR6","doi-asserted-by":"publisher","first-page":"e5606","DOI":"10.1097\/MD.0000000000005606","volume":"95","author":"J Tu","year":"2016","unstructured":"Tu J, Jia Z, Ying X, Zhang D, Li S, Tian F, Jiang G (2016) The incidence and outcome of major complication following conventional TAE\/TACE for hepatocellular carcinoma. Medicine (Baltimore) 95 (49):e5606. \n                    https:\/\/doi.org\/10.1097\/md.0000000000005606","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"2203_CR7","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1148\/radiographics.18.3.9599386","volume":"18","author":"I Sakamoto","year":"1998","unstructured":"Sakamoto I, Aso N, Nagaoki K, Matsuoka Y, Uetani M, Ashizawa K, Iwanaga S, Mori M, Morikawa M, Fukuda T, Hayashi K, Matsunaga N (1998) Complications associated with transcatheter arterial embolization for hepatic tumors. Radiographics 18 (3):605-619. \n                    https:\/\/doi.org\/10.1148\/radiographics.18.3.9599386","journal-title":"Radiographics"},{"issue":"6","key":"2203_CR8","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.brachy.2013.05.008","volume":"12","author":"JL Peterson","year":"2013","unstructured":"Peterson JL, Vallow LA, Johnson DW, Heckman MG, Diehl NN, Smith AA, Tzou KS, Paz-Fumagalli R, Kim S, Ko SJ, Daugherty LC, Kim GP, Brown N, Mori KW, Buskirk SJ (2013) Complications after 90Y microsphere radioembolization for unresectable hepatic tumors: An evaluation of 112 patients. Brachytherapy 12 (6):573-579. \n                    https:\/\/doi.org\/10.1016\/j.brachy.2013.05.008","journal-title":"Brachytherapy"},{"issue":"10","key":"2203_CR9","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1007\/s00261-017-1168-6","volume":"42","author":"H Onizuka","year":"2017","unstructured":"Onizuka H, Sueyoshi E, Ishimaru H, Sakamoto I, Uetani M (2017) Arterial injury during transcatheter arterial chemoembolization for hepatocellular carcinoma: predictors of risk and outcome. Abdom Radiol (NY) 42 (10):2544-2550. \n                    https:\/\/doi.org\/10.1007\/s00261-017-1168-6","journal-title":"Abdom Radiol (NY)"},{"issue":"1","key":"2203_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/BF02807349","volume":"18","author":"DY Yoon","year":"1995","unstructured":"Yoon DY, Park JH, Chung JW, Han JK, Han MC (1995) Iatrogenic dissection of the celiac artery and its branches during transcatheter arterial embolization for hepatocellular carcinoma: outcome in 40 patients. Cardiovasc Intervent Radiol 18 (1):16-19","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"7","key":"2203_CR11","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1177\/0284185116676654","volume":"58","author":"E Jung","year":"2017","unstructured":"Jung E, Shin JH, Kim JH, Yoon HK, Ko GY, Sung KB (2017) Arterial dissections during transcatheter arterial chemoembolization for hepatocellular carcinoma: a 19-year clinical experience at a single medical institution. Acta Radiol 58 (7):842-848. \n                    https:\/\/doi.org\/10.1177\/0284185116676654","journal-title":"Acta Radiol"},{"issue":"3","key":"2203_CR12","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1053\/tvir.2002.36422","volume":"5","author":"M Gee","year":"2002","unstructured":"Gee M, Soulen MC (2002) Chemoembolization for hepatic metastases. Tech Vasc Interv Radiol 5 (3):132-140. \n                    https:\/\/doi.org\/10.1053\/tvir.2002.36422","journal-title":"Tech Vasc Interv Radiol"},{"issue":"3","key":"2203_CR13","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1097\/RLU.0000000000001532","volume":"42","author":"C Chao","year":"2017","unstructured":"Chao C, Stavropoulos SW, Mondschein JI, Dagli M, Sudheendra D, Nadolski G, Soulen MC (2017) Effect of Substituting 50% Isovue for Sterile Water as the Delivery Medium for SIR-Spheres: Improved Dose Delivery and Decreased Incidence of Stasis. Clin Nucl Med 42 (3):176-179. \n                    https:\/\/doi.org\/10.1097\/rlu.0000000000001532","journal-title":"Clin Nucl Med"},{"issue":"3","key":"2203_CR14","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s00270-015-1208-y","volume":"39","author":"T de Baere","year":"2016","unstructured":"de Baere T, Arai Y, Lencioni R, Geschwind JF, Rilling W, Salem R, Matsui O, Soulen MC (2016) Treatment of Liver Tumors with Lipiodol TACE: Technical Recommendations from Experts Opinion. Cardiovasc Intervent Radiol 39 (3):334-343. \n                    https:\/\/doi.org\/10.1007\/s00270-015-1208-y","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"7","key":"2203_CR15","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.jvir.2007.04.018","volume":"18","author":"AT Ruutiainen","year":"2007","unstructured":"Ruutiainen AT, Soulen MC, Tuite CM, Clark TW, Mondschein JI, Stavropoulos SW, Trerotola SO (2007) Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver. J Vasc Interv Radiol 18 (7):847-855. \n                    https:\/\/doi.org\/10.1016\/j.jvir.2007.04.018","journal-title":"J Vasc Interv Radiol"},{"key":"2203_CR16","doi-asserted-by":"publisher","unstructured":"Brown DB, Nikolic B, Covey AM, Nutting CW, Saad WE, Salem R, Sofocleous CT, Sze DY, Society of Interventional Radiology Standards of Practice C (2012) Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy. J Vasc Interv Radiol 23 (3):287-294. \n                    https:\/\/doi.org\/10.1016\/j.jvir.2011.11.029","DOI":"10.1016\/j.jvir.2011.11.029"},{"issue":"2","key":"2203_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1055\/s-2006-941442","volume":"23","author":"TW Clark","year":"2006","unstructured":"Clark TW (2006) Complications of hepatic chemoembolization. Semin Intervent Radiol 23 (2):119-125. \n                    https:\/\/doi.org\/10.1055\/s-2006-941442","journal-title":"Semin Intervent Radiol"},{"issue":"4","key":"2203_CR18","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s11604-007-0216-5","volume":"26","author":"N Maeda","year":"2008","unstructured":"Maeda N, Osuga K, Mikami K, Higashihara H, Onishi H, Nakaya Y, Tatsumi M, Hori M, Kim T, Tomoda K, Nakamura H (2008) Angiographic evaluation of hepatic arterial damage after transarterial chemoembolization for hepatocellular carcinoma. Radiat Med 26 (4):206-212. \n                    https:\/\/doi.org\/10.1007\/s11604-007-0216-5","journal-title":"Radiat Med"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-019-02203-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00261-019-02203-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-019-02203-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T23:37:25Z","timestamp":1598657845000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00261-019-02203-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,30]]},"references-count":18,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["2203"],"URL":"https:\/\/doi.org\/10.1007\/s00261-019-02203-z","relation":{},"ISSN":["2366-004X","2366-0058"],"issn-type":[{"value":"2366-004X","type":"print"},{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,30]]},"assertion":[{"value":"30 August 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Erica Alexander declares that she has no conflicts of interest. Gregory Nadolski receives research support from Guerbet LCC and Teleflex. Michael Soulen receives research support from Guerbet LCC and BTG International, is a consultant for Guerbet LCC and Genentech, and is a proctor for Sirtex. S. William Stavropoulos is a consultant for Becton\u2013Dickinson and receives research support from Cook and Sillajen. Stephen Hunt is a consultant for BTG and receives research grants from BTG, SIO, SIR, and RSNA. Terence Gade is a consultant for Trisalus and received an investigator initiation grant from Guerbet LLC. Max Itkin has no related conflicts to declare. Susan Shamimi-Noori is a proctor for Sirtex.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}